| Net income (loss) | -5.29M |
| Depreciation and amortization expense | |
| Share-based compensation expense | 115K |
| Accounts receivable | 1.09M |
| Inventories | 227K |
| Other current assets | -148K |
| Other asset | |
| Trade accounts payable | 1.22M |
| Accrued compensation | 271K |
| Other accrued liabilities | -587K |
| Net cash provided by (used in) operating activities | -1.77M |
| Purchase of property and equipment | -51K |
| Collection of note receivable | |
| Net cash provided by (used in) investing activities | 270K |
| Proceeds from exercise of stock options | |
| Net cash provided by financing activities | 961K |
| Net increase (decrease) in cash and cash equivalents | -539K |
| Cash and cash equivalents at beginning of period | 624K |
| Cash and cash equivalents at end of period | 85K |